Oral treatments for Benign Prostatic Hyperplasia (BPH) are an effective option for mild cases of prostate enlargement, providing a useful solution for prostate growth in moderate situations. The urologists at Andrología Barcelona incorporate these treatments into their therapeutic approach.
Oral Medications for Treating Benign Prostatic Hyperplasia (BPH)
The main goal in treating Benign Prostatic Hyperplasia (BPH) is to manage prostate growth and relieve associated symptoms, rather than just addressing the side effects.
BPH may be linked to modifiable factors, such as certain lifestyle habits or the use of medications. These factors are often addressed before starting a specific treatment or in combination with it.
How can oral medications help a patient with BPH?
The goal of oral medications for Benign Prostatic Hyperplasia (BPH) is to relieve the symptoms associated with prostate enlargement. These medications help improve urine flow and reduce discomfort, facilitating better urinary function.
Although oral medications are usually effective for many patients, their efficacy can vary depending on the degree of prostate growth and the individual characteristics of the patient. Therefore, it is crucial to follow medical guidelines and ensure proper monitoring.
At Andrología Barcelona, we emphasize the importance of consulting with a urologist to adjust the treatment according to specific needs. Our team is prepared to offer personalized solutions and ensure the best management of Benign Prostatic Hyperplasia (BPH).
There are several types of oral medications used to treat Benign Prostatic Hyperplasia (BPH). These drugs are divided into two main categories: alpha-blockers and 5-alpha-reductase inhibitors.
How does each medication for Benign Prostatic Hyperplasia (BPH) affect and work?
Depending on the patient’s individual response to the medication, the duration of its effects, tolerance, price, and ease of use, at Andrología Barcelona, we recommend one type of medication or another for Benign Prostatic Hyperplasia.
In general, the available treatments can be very effective in controlling symptoms and improving the patient’s quality of life, although they do not always provide a definitive solution. This means the patient may experience significant relief from symptoms, but the effectiveness can depend on the treatment chosen.
In some cases, the treatment of Benign Prostatic Hyperplasia (BPH) may vary, especially in situations with additional complications or specific needs, where therapeutic options can be adjusted to achieve the best possible outcome. Some of the most commonly used treatments are:
Alpha-blockers
Alpha-blockers help relax the muscles of the prostate and bladder, facilitating urine flow.
Some of the most common include Tamsulosin (Omnic Ocas), Alfuzosin (Unibenestan), Silodosin (Silodyx), Terazosin (Alfaprost), and Doxazosin (Carduran).
5-alpha-reductase inhibitors
These medications work by reducing the size of the prostate by blocking the conversion of testosterone into dihydrotestosterone (DHT), which is responsible for prostate growth.
The main ones include: Finasteride (Proscar) and Dutasteride (Avodart).
Combination of Alpha-blockers and 5-alpha-reductase Inhibitors
Some treatments combine both types of medications to address Benign Prostatic Hyperplasia (BPH) from different angles and improve symptoms more comprehensively.
An example of a combined treatment is the combination of Tamsulosin and Dutasteride (Duodart). This option combines an alpha-blocker and a 5-alpha-reductase inhibitor into a single pill, providing an integrated solution to reduce prostate size and improve urinary flow. Among its benefits are faster symptomatic relief due to the alpha-blocker and long-term prostate size reduction from the 5-alpha-reductase inhibitor.
This combination may be more effective for some patients, especially those with severe symptoms or those who have not responded adequately to a single medication type.
¿Why is it important to treat benign prostatic hyperplasia (BPH)?
Although Benign Prostatic Hyperplasia (BPH) is a non-cancerous condition, it can have a significant impact on the physical and emotional health of patients, as well as on their quality of life and that of their families.
A study conducted in Spain, known as the Prevalence and Characteristics of Benign Prostatic Hyperplasia in the Adult Male Population (BPH-S Study), revealed that BPH affects approximately 40% of men over 50 years old. This study, carried out in various regions of the country, showed that the prevalence of urinary symptoms related to BPH increases with age and can reach 60% in men aged 70 or older. The results emphasize the importance of addressing this condition due to its significant impact on the quality of life of patients.
Would you like more information about oral medications for BPH?
At Andrología Barcelona, we are experts in the treatment of Benign Prostatic Hyperplasia (BPH). Feel free to reach out with any questions you may have.